ClinConnect ClinConnect Logo
Search / Trial NCT05521451

Clinical Cohort Study - TRUST

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Aug 26, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Catheter Ablation Biomarkers Cardiac Arrhythmia E Health Digital Cardiology Echocardiography Atrial Cardiomyopathy

ClinConnect Summary

The TRUST study is a research project aimed at understanding the long-term outcomes and factors that may predict whether heart rhythm problems (called arrhythmias) will come back after treatment. This study is taking place at the University Heart Center Hamburg and includes patients who have been treated for various types of arrhythmias or are at high risk for them. By collecting detailed information about patients and their treatments, researchers hope to gain important insights that could improve future care for people with these conditions.

To participate in the study, you must be at least 18 years old and have a diagnosed heart arrhythmia or be at high risk for one. You will need to provide written consent and be able to understand the study information, as the documents are in German. If you join the study, you can expect to share your experiences and have your health monitored over time, which may help doctors better understand and treat arrhythmias in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia
  • Age ≥ 18 years
  • Written informed consent
  • Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation
  • Exclusion Criteria:
  • Insufficient knowledge of the German language to understand study documents and interview without translation
  • Physical or psychological incapability to cooperate in the investigation

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Hamburg, , Germany

Patients applied

0 patients applied

Trial Officials

Paulus Kirchhof, MD

Principal Investigator

Universitätsklinikum Hamburg-Eppendorf

Andreas Metzner, MD

Principal Investigator

Universitätsklinikum Hamburg-Eppendorf

Andreas Rillig, MD

Principal Investigator

Universitätsklinikum Hamburg-Eppendorf

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials